8ᵗʰ International Symposium on Hodgkin Lymphoma
back to
back to
Program
Schedule
23.10.2010
24.10.2010
25.10.2010
26.10.2010
Scientific Committee
Media
Photos
Videos
Downloads
Acknowledgements
Sponsors
Other Archives
ISHL12
Update on Hodgkin Lymphoma
ISHL11
ISHL10
ISHL9
ISHL8
ISHL7
Back to video list
LBH-589
Speaker
Anas Younes
Session
New drugs
Others Talks of this Session
SGN-35
Everolimus for Relapsed/Refractory HL
Initial Results from the SAPHIRE Study: a Phase II Trial with the Novel Oral Histone Deacetylase (HDAC) Inhibitor Resminostat in Relapsed or Refractory Hodgkin Lymphoma Patients
This website uses cookies to ensure you get the best experience on our website. By using our site you agree to our use of cookies.
Learn more
Got it!